Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander G Bick

Showing results (91-100 of 205) with videos related to

Pageof 21
Sort By:
Haematologica|November 14, 2024
Germline genetics, disease, and exposure to medication influence longitudinal dynamics of clonal hematopoiesisTaralynn Mack, Yash Pershad, Caitlyn Vlasschaert, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Increased CHIP Prevalence Amongst People Living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
Scientific Reports|January 13, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
Nature Communications|August 22, 2020
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditionsAkl C Fahed, Minxian Wang, Julian R Homburger, et al.
Journal of the American College of Cardiology|May 17, 2023
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular DiseaseEsra D Gumuser, Art Schuermans, So Mi Jemma Cho, et al.
Blood Cancer Journal|January 15, 2024
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation riskAshwin Kishtagari, M A Wasay Khan, Yajing Li, et al.
Scientific Reports|July 8, 2022
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
Blood Advances|April 14, 2022
Patient-specific comorbidities as prognostic variables for survival in myelofibrosisAndrew L Sochacki, Cosmin Adrian Bejan, Shilin Zhao, et al.
Circulation|February 15, 2024
Clonal Hematopoiesis of Indeterminate Potential With Loss of <i>Tet2</i> Enhances Risk for Atrial Fibrillation Through <i>Nlrp3</i> Inflammasome ActivationAmy Erica Lin, Aneesh C Bapat, Ling Xiao, et al.
JAMA Cardiology|April 10, 2024
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1Seyedmohammad Saadatagah, Mohammadreza Naderian, Mesbah Uddin, et al.
Pageof 21

Showing results (91-100 of 205) with videos related to

Sort By:
Pageof 21
Haematologica|November 14, 2024
Germline genetics, disease, and exposure to medication influence longitudinal dynamics of clonal hematopoiesisTaralynn Mack, Yash Pershad, Caitlyn Vlasschaert, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Increased CHIP Prevalence Amongst People Living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
Scientific Reports|January 13, 2022
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
Nature Communications|August 22, 2020
Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditionsAkl C Fahed, Minxian Wang, Julian R Homburger, et al.
Journal of the American College of Cardiology|May 17, 2023
Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular DiseaseEsra D Gumuser, Art Schuermans, So Mi Jemma Cho, et al.
Blood Cancer Journal|January 15, 2024
Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation riskAshwin Kishtagari, M A Wasay Khan, Yajing Li, et al.
Scientific Reports|July 8, 2022
Author Correction: Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIVAlexander G Bick, Konstantin Popadin, Christian W Thorball, et al.
Blood Advances|April 14, 2022
Patient-specific comorbidities as prognostic variables for survival in myelofibrosisAndrew L Sochacki, Cosmin Adrian Bejan, Shilin Zhao, et al.
Circulation|February 15, 2024
Clonal Hematopoiesis of Indeterminate Potential With Loss of <i>Tet2</i> Enhances Risk for Atrial Fibrillation Through <i>Nlrp3</i> Inflammasome ActivationAmy Erica Lin, Aneesh C Bapat, Ling Xiao, et al.
JAMA Cardiology|April 10, 2024
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1Seyedmohammad Saadatagah, Mohammadreza Naderian, Mesbah Uddin, et al.
Pageof 21